A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Concepedia

Concepedia

Publication | Closed Access

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

160

Citations

12

References

2011

Year

A. W. Tolcher, David I. Quinn, Anna C. Ferrari, Frederick R. Ahmann, Giuseppe Giaccone, T. Drake, Anne Keating, Johann S. de Bono

Annals of Oncology

UrologyGenitourinary CancerMedicineNovel Small-molecule SuppressorPharmacologyPhase Ii StudyAnti-cancer AgentTumor SuppressorProstatic DiseaseOncologyMolecular Oncology

References

	Year	Citations

Page 1

Page 1